分子癌癥研究發(fā)表文章描述了對(duì)該領(lǐng)域有廣泛興趣的新的基礎(chǔ)癌癥研究發(fā)現(xiàn)。研究必須具有證明意義，并且該雜志將分子和細(xì)胞水平的分析放在首位，揭示了與癌癥風(fēng)險(xiǎn)、發(fā)展和/或進(jìn)展相關(guān)的途徑和過程的新的機(jī)械洞察。重點(diǎn)領(lǐng)域包括所有癌癥相關(guān)途徑（包括細(xì)胞周期調(diào)節(jié)、細(xì)胞死亡、染色質(zhì)調(diào)節(jié)、DNA損傷和修復(fù)、基因和RNA調(diào)節(jié)、基因組學(xué)、癌基因和腫瘤抑制因子以及信號(hào)轉(zhuǎn)導(dǎo)），以及描述支持癌癥表型的新分子機(jī)制和相互作用的研究。為了充分考慮，提交的初步研究必須提供對(duì)現(xiàn)有通路功能的重要新見解，或解決與癌癥相關(guān)的生物學(xué)問題相關(guān)的新假設(shè)。分子癌癥研究接受提交的初步研究，評(píng)論和評(píng)論文章類型以及給編輯的信件。有關(guān)提交給作者的文章類型的描述和長度要求，請(qǐng)參閱分子癌癥研究的文章類別。AACR期刊都使用類似的編輯過程。請(qǐng)注意，分子癌癥研究不考慮上訴。提交作者必須熟悉AACR期刊的編輯政策，包括關(guān)于作者身份、出版道德、材料和數(shù)據(jù)的可用性以及數(shù)據(jù)分析和報(bào)告的重要信息。對(duì)手稿進(jìn)行嚴(yán)格的審查，以獲得高標(biāo)準(zhǔn)的科學(xué)價(jià)值，只有那些報(bào)告小說、及時(shí)和廣泛重要研究成果的手稿才被接受出版。

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.Molecular Cancer Research accepts submissions of primary research, review and commentary article types as well as letters to the editor. For descriptions and length requirements of the article types available to submitting authors see the Categories of Articles for Molecular Cancer Research. The AACR Journals all use a similar Editorial Process. Please note that Molecular Cancer Research does not consider appeals.Submitting authors must be familiar with the Editorial Policies of the AACR Journals covering important information on authorship, publishing ethics, availability of materials and data and data analysis and reporting.Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication.